This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Allergan PLC (AGN)

: Health Care

Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) 3.92B -1.63B -751.10M 98.30M
Operating Gains/Losses 0.00 -102.10M -5.70M -30.10M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -1.03B -611.10M 19.10M 371.10M
(Increase) Decrease in Inventories -226.20M -207.20M -213.10M -6.20M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 142.50M 416.50M -20.40M -222.70M
(Decrease) Increase In Other Current Liabilities -87.80M 29.70M 7.40M -130.60M
(Increase) Decrease In Other Working Capital -137.30M -89.20M -6.50M -6.20M
Other Non-Cash Items 1.67B 1.21B 1.04B 214.10M
Net Cash From Continuing Operations 4.53B 2.28B 1.18B 665.80M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 4.53B 2.28B 1.18B 665.80M
Sale of Property, Plant & Equipment 140.10M 13.70M 7.10M 8.00M
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 33.20M 58.90M
Purchases of Property, Plant & Equipment -609.60M -274.70M -307.90M -146.50M
Acquisitions -37.51B -5.56B -15.10M -5.74B
Purchases of Short-Term Investments 0.00 0.00 0.00 -156.70M
Other Cash from Investing Activities 0.00 441.70M 7.40M 235.30M
Cash Provided by Financing Activities
Net Cash From Investing Activities -37.12B -5.37B -275.30M -5.75B
Issuance of Debt 30.14B 9.36B 2.44B 6.04B
Cash Used for Financing Activities
Issuance of Capital Stock 9.00B 0.00 48.00M 18.80M
Repayment of Long-Term Debt -5.13B -6.13B -3.23B 0.00
Repurchase of Capital Stock -118.00M -130.10M -170.00M -16.10M
Payment of Cash Dividends -208.10M 0.00 0.00 0.00
Other Financing Charges, Net -234.80M -81.60M 46.90M -853.60M
Net Cash From Financing Activities 33.44B 3.02B -867.30M 5.19B
Effect of Exchange Rate Changes -6.50M -5.90M -23.90M 3.30M
Net Change in Cash & Cash Equivalents 846.00M -79.00M 10.00M 109.70M
AGN News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for AGN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 10 9 9 10
Moderate Buy 3 2 2 2
Hold 4 0 0 0
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0

AGN Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs